PUBLIC CONTRACT · 2019
Aquisição de medicamento com a substância ativa anagrelida
- Contract value
- €7,068.00
- Signed on
- 26 June 2019
- Procedure
- Prior consultation (Consulta Prévia)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5687110PUBLISHED SUBJECT
Aquisição de medicamento com a substância ativa anagrelida
Parties involved
- Awardee
- - - TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA
- Bidder
- GENERIS FARMACÊUTICA,SA · Tax ID 508107997
- Bidder
- SHIRE PHARMACEUTICALS PORTUGAL, LDA · Tax ID 509264662
- Bidder
- TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
Values and timeline
- Contract price
- €7,068.00
- Procedure base price
- €7,708.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 8 July 2019
- Award date
- 26 June 2019
- Signing date
- 26 June 2019
- Performance period
- 190 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Prior consultation (Consulta Prévia)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33650000-1 - Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores
- Legal basis
- Artigo 20.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4051017
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.